Back to Search
Start Over
Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells
- Source :
- Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩, Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩
- Publication Year :
- 2019
- Publisher :
- HAL CCSD, 2019.
-
Abstract
- International audience
- Subjects :
- Antitumor activity
Chemistry
In vivo
Covalent bond
Drug Discovery
Cancer research
Molecular Medicine
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Discovery and development of mTOR inhibitors
[SDV.BC] Life Sciences [q-bio]/Cellular Biology
Triple-negative breast cancer
ComputingMilieux_MISCELLANEOUS
3. Good health
Subjects
Details
- Language :
- English
- ISSN :
- 00222623 and 15204804
- Database :
- OpenAIRE
- Journal :
- Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩, Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩
- Accession number :
- edsair.doi.dedup.....3458dce9a9baf7d4d7aeec3ee6a28286
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.9b01578⟩